DNA Synthesis Market to Grow by USD 6.5 Billion from 2024-2028, Driven by Rising Demand for DNA-Based Therapeutics, AI-Powered Report by Technavio [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
The market is estimated to grow at a CAGR of 18.1% during the forecast period. Increasing use of dna synthesis-based therapeutics is driving market growth, with a trend towards integration of automation in dna synthesis. However, regulatory issues associated with dna synthesis therapeutics poses a challenge. Key market players include Azenta US, Inc, Bio Basic Inc., BioCat GmbH, Biomatik Corp., Bioneer Corp., Danaher Corp., DNA Script, Epoch Life Science, Eton Bioscience Inc., Eurofins Scientific SE, Evonetix Ltd, Gene Universal, Inc., Genemed Synthesis Inc., GenScript Biotech Corp., OriGene Technologies Inc., ProMab Biotechnologies, Inc, Proteo Genix, Synbio Technologies LLC, Thermo Fisher Scientific Inc., and Twist Bioscience Corp.. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now Forecast period Base Year Historic Data Segment Covered Type (Oligonucleo
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Danaher Co. (NYSE: DHR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $285.00 price target on the stock.MarketBeat
- Videojet to Showcase Innovative Coding and Marking Solutions at Pack Expo 2024 [Yahoo! Finance]Yahoo! Finance
- ViewSonic Launches its First Thunderbolt 4 Docking Monitor [Yahoo! Finance]Yahoo! Finance
- X-Rite, Pantone, and Sun Chemical Add Color Libraries to PantoneLIVE for Extruded Aluminum Aerosol PackagingPR Web
- BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 10/22/24 - Beat
DHR
Sec Filings
- 10/28/24 - Form 4
- 10/28/24 - Form 4
- 10/28/24 - Form 4
- DHR's page on the SEC website